🚨 Applications are now OPEN for the ERN ReCONNET Transition of Care Accredited Training!
📍 Ljubljana, Slovenia
📅 22–24 Oct 2026 + 6-week virtual programme
📢 Apply by 24 Aug 2026
👉 https://t.co/nGjxRrhWIK
#ERNReCONNET#RareDiseases#TransitionOfCare@EU_HaDEA@EU_Commission
🎓 The @ern_reconnet#webinar “Hydroxychloroquine in connective tissue diseases: benefits and controversial aspects” is now available on our YouTube channel!
🔗You can access the webinar here: https://t.co/DExb9iuK1J
🌐 More info on UCTD here: https://t.co/BjB7FQc8Wz
Don’t miss TODAY’S @ERNReCONNET webinar at 16 CET on “Hydroxychloroquine in connective tissue diseases: benefits and controversial aspects” with Prof. Chiara Tani, moderated by Prof. Cristina Pamfil.
✍️ Make sure you're registered to participate: https://t.co/hxdRpBZfwi
Register now for the 🆕@ern_reconnet#webinar “Hydroxychloroquine in connective tissue diseases: benefits and controversial aspects” with Prof. Chiara Tani, moderated by Prof. Cristina Pamfil.
🗓️July 08th - 16 CET
✍️Registration is: https://t.co/hxdRpBZfwi
🎓 The @ern_reconnet#webinar “Kidney involvement in Sjögren’s Disease (SjD)” is now available on our YouTube channel!
🔗You can access the webinar here: https://t.co/aF70AI1Jrv
🌐 More info on SjD here: https://t.co/8DCmYrQusQ
Don’t miss TODAY’S @ERNReCONNET webinar at 16 CET on “Kidney involvement in Sjögren’s Disease (SjD)” with Dr. Andreas Goules, moderated by Prof. Gaetane Nocturne and the ePAG Ana Vieira.
✍️ Make sure you're registered to participate: https://t.co/Nnylt11g7u
Register now for the 🆕@ern_reconnet#webinar “Kidney involvement in Sjögren’s Disease (SjD)” with Dr. Andreas Goules, moderated by Prof. Gaetane Nocturne and the ePAG Ana Vieira.
🎯Audience: healthcare professionals
🗓️June 24th - 16 CET
✍️Registration is: https://t.co/Nnylt11NX2
🎓 The @ern_reconnet#webinar “Systemic sclerosis and pregnancy, a 2026 update” is now available on our YouTube channel!
🔗You can access the webinar here: https://t.co/pxDSO1zZwp
🌐 More info on SSc here: https://t.co/sGsJFArPtl
Don’t miss TODAY’S @ERNReCONNET webinar at 16 CET on “Systemic sclerosis and pregnancy, a 2026 update” with Dr. Benjamin Chaigne, moderated by Prof. David Launay.
✍️ Make sure you're registered to participate: https://t.co/zT81bWp5MS
🎓 The @ern_reconnet#webinar “How to find hidden Antiphospholipid Syndrome (APS)” is now available on our YouTube channel!
🔗You can access the webinar here: https://t.co/z1fzEYldd4
🌐 More info on APS here: https://t.co/wzqiZsR0Dk
Don’t miss TODAY’S @ERNReCONNET webinar at 16 CET on “How to find hidden Antiphospholipid Syndrome (APS)” with Dr. Paola Triggianese and Prof. Angela Tincani, moderated by Prof. Savino Sciascia.
✍️ Make sure you're registered to participate: https://t.co/KHaX0pbpiA
Register now for the 🆕@ern_reconnet#webinar “Systemic sclerosis and pregnancy, a 2026 update” with Dr. Benjamin Chaigne, moderated by Prof. David Launay.
🗓️June 17th - 16 CET
✍️Register here: https://t.co/zT81bWp5MS
⚙️ on SSc: https://t.co/sGsJFArPtl
🩷ERN ReCONNET stands with the global community on #WorldAPSday!🌍
🌐 Resources on APS: https://t.co/wzqiZsR0Dk
🎥 ERN ReCONNET webinars on APS: https://t.co/JzPDqj2eVh
🗞 Stay updated — subscribe to our newsletter: https://t.co/jD2FsfjMZU
🆕@ern_reconnet#webinar “How to find hidden Antiphospholipid Syndrome (APS)” with Dr. Paola Triggianese and Prof. Angela Tincani, moderated by Prof. Savino Sciascia.
🗓️June 10th - 16 CET
✍️Registration is: https://t.co/KHaX0pbpiA
⚙️ on APS: https://t.co/wzqiZsR0Dk
🇬🇧 From London to Berlin 🇩🇪 #EULAR2026
Extraordinary days are closing.
Now Stay Tuned!
🌐 Website: https://t.co/SIvFOTMZn4
📩 Newsletter: https://t.co/01vJ6khpsq
See you in Berlin at #EULAR2027! 🇩🇪
The science continues together.
Day 3 at #EULAR2026 – London
We are making the most of every moment here at Booth O13!
✅TWO SURVEYS OPEN
➡️Transition Survey👉https://t.co/aIBrir3p8v
➡️ Digital Lesions Survey👉https://t.co/UbifJ7RLHc
🇬🇧 Day 2 at #EULAR2026 – London 🇬🇧
We are thrilled by the remarkable interest shown in the TogethERN ReCONNET Registry.
Real-World Data collection is key to advancing the understanding and management of rCTDs.
📣 Stay tuned!!
We will have more to share very soon!